Annals of the Rheumatic Diseases

Papers
(The H4-Index of Annals of the Rheumatic Diseases is 74. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Correction: Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study784
POS0760 HIGH LEVELS OF PROTEINS, CELL COUNTS, AND IL-6 IN CEREBROSPINAL FLUID IN PATIENTS WITH NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH DAMAGE ACCRUAL OF NON-NEUROPSYCHIATRIC 526
OP0089 RNAseq PROFILING OF RHEUMATOID ARTHRITIS PATIENTS TO PREDICT RESPONSE TO TOFACITINIB513
POS0775 COMBINED MODEL OF RENAL HISTOPATHOLOGY AND CLINICAL PARAMETERS BETTER PREDICT ONE YEAR RENAL OUTCOMES IN LUPUS NEPHRITIS: ANALYSIS OF 334 KIDNEY BIOPSIES481
POS0518 EFFECT OF FILGOTINIB (FIL) ON BODY WEIGHT (BW) AND BODY MASS INDEX (BMI) AND EFFECT OF BASELINE BMI ON THE EFFICACY AND SAFETY OF FIL IN RHEUMATOID ARTHRITIS (RA)319
POS1576-PARE IMPROVING METHOTREXATE PRESCRIBING AND DISPENSING SAFETY THROUGH A SIMPLE ADJUSTMENT TO ELECTRONIC PRESCRIBING.304
POS0481 DEFINING DISTINCT RESIDENT AND MIGRATORY FIBROBLAST POPULATIONS FROM SKIN BIOPSIES IN SYSTEMIC SCLEROSIS271
POS0972 MOST DISEASE OUTCOME MEASURES BUT NOT ASDAS ARE INFLUENCED BY GENDER IN PATIENTS WITH AXIAL SpA: RESULTS FROM ASAS-PerSpA270
POS0033 GENETIC INVESTIGATION OF TUMOUR NECROSIS FACTOR INHIBITOR IMMUNOGENICITY IN PATIENTS WITH RHEUMATOID ARTHRITIS269
OP0128 ADHERENCE TO MEDICATIONS DURING PREGNANCY IN SYSTEMIC AUTOIMMUNE DISEASE265
AB0107 IMPACT OF SARS-CoV-2 INFECTION ON THE DISEASE ACTIVITY OF PATIENTS WITH PSORIATIC ARTHRITIS UNDER bDMARDs: REAL LIFE DATA256
POS0048-HPR HEALTHCARE PROFESSIONALS' EXPERIENCES OF LIFESTYLE MANAGEMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS – A QUALITATIVE STUDY250
POS1036 EFFICACY AND SAFETY OF RISANKIZUMAB (RZB) FOR ACTIVE PSORIATIC ARTHRITIS (PsA): 52-WEEK RESULTS FROM KEEPsAKE 2228
POS1039 DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN A PHASE 2 TRIAL IN PSORIATIC ARTHRITIS: ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY AND ITS COMPONENTS227
POS1451 DISCRIMINATORY CAPACITY OF THE ASAS HEALTH INDEX IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED IN A TIGHT CONTROL SETTING VERSUS STANDARD OF CARE212
POS1011 THE STUDY OF DETECTION OF FECAL CALPROTECTIN AS A MARKER OF EARLY DIAGNOSIS OF THE DEVELOPMENT OF INFLAMMATORY BOWEL DISEASES IN PATIENTS WITH ANKYLOSING SPONDYLITIS212
POS1383 DIFFERENTIAL DIAGNOSTICS OF POLYMYALGIA RHEUMATICA IN A UNIVERSITY HOSPITAL IN FINLAND211
OP0240 ZOLEDRONATE-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROSIS: INCIDENCE, RISK FACTORS AND COMPARISON TO ORAL BISPHOSPHONATES207
OP0110 CELL-TYPE-SPECIFIC TRANSCRIPTOME ARCHITECTURE UNDERLYING THE ESTABLISHMENT AND EXACERBATION OF SYSTEMIC LUPUS ERYTHEMATOSUS202
POS1207 SEROCONVERSION AFTER A THIRD COVID-19 VACCINATION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH (ULTRA-)LOW DOSE RITUXIMAB WITH A PREVIOUS INSUFFICIENT HUMORAL RESPONSE IS DEPENDENT ON RITUXIM202
POS0018 REDUCTION OF DIFFUSE NOXIOUS INHIBITORY CONTROL IN ACTIVE INFLAMMATORY RHEUMATISM: A DEMONSTRATION OF CENTRAL SENSITISATION198
AB0031 DEEP IMMUNE PHENOTYPING OF SLE AND RA BY MACHINE LEARNING180
POS0045-HPR HEALTHCARE PROFESSIONALS' ATTITUDE TOWARDS REMOTE MONITORING180
POS1526-HPR WHICH FACTORS INFLUENCE PATIENTS' PREFERENCES FOR TELEHEALTH APPLICATIONS IN RHEUMATIC DISEASES? A QUALITATIVE STUDY174
POS0225 FLUIDIC SHEAR STRESS REDUCES TNFΑ-MEDIATED CARTILAGE DAMAGE IN A 3D MODEL OF DEGENERATIVE JOINT DISEASE171
POS0740 IMPACT OF TIME TO REMISSION, FLARES AND EXPOSURE TO IMMUNOSUPPRESSIVES ON THE DEVELOPMENT OF ADVANCED CHRONIC KIDNEY DISEASE (STAGE IV OR WORSE) IN LUPUS NEPHRITIS168
POS0883 BIOPHYSICAL PROPERTIES OF MONOCYTES INDICATE DISEASE ACTIVITY, SEVERITY OF FIBROTIC OR MICROVASCULAR MANIFESTATIONS AND THE RISK FOR PROGRESSION IN SYSTEMIC SCLEROSIS163
POS1258 LESS THAN EXPECTED IMPACT OF RHEUMATOID ARTHRITIS AND AXIAL SPONDYLOARTHRITIS DISEASE ON COVID SEVERITY162
POS0562 AUTOANTIBODIES TO JOINT PROTEINS AS NOVEL BIOMARKERS FOR THE DIAGNOSIS OF UNTREATED EARLY RHEUMATOID ARTHRITIS159
POS0746 MEASUREMENT OF ANTI-SUPRABASIN ANTIBODIES, MULTIPLE CYTOKINES AND CHEMOKINES AS POTENTIAL PREDICTIVE BIOMARKERS FOR NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS158
AB0999 Osteoarthritis. Pharmacoeconomics aspects of symptom-modifying therapy in real clinical practice.154
AB0428 TREATMENT PATTERNS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN TAIWAN – A POPULATION-BASED ANALYSIS154
AB0290 COMPARATIVE FEATURES AND LONGITUDINAL BEHAVIOUR OF RHEUMATOID ARTHRITIS-ASSOCIATED UIP VERSUS IDIOPATHIC PULMONARY FIBROSIS: A SINGLE CENTRE COHORT STUDY143
AB0609 Gaps in the diagnosis of Takayasu Arteritis: a Romanian cohort142
AB1389 COST-MINIMIZATION ANALYSIS IN RHEUMATOID ARTHRITIS IN SPAIN140
AB1164 EFFICACY AND TOLERABILITY OF THE VACCINE AGAINST SARS- CoV-2 IN PATIENTS WITH SJOGREN'S SYNDROME RECEIVING VARIOUS TYPES OF THERAPY.136
AB0777 Influence of TNF inhibitors on subclinical atherosclerosis in Spondyloarthritis patients134
AB1374 INTERSTITIAL LUNG DISEASE IN ASYMPTOMATIC PATIENTS AT THE ONSET OF INFLAMMATORY RHEUMATIC DISEASES132
AB1134 BIBLIOMETRIC NETWORK ANALYSIS ON TOCILIZUMAB TREATMENT FOR COVID-19 PATIENTS132
AB0842 Foot entheses ultrasound in spondyloarthritis: a case control study130
AB1349 CORRELATION OF CHRONIC INFLAMMATION MARKERS WITH ULTRASOUND SIGNS OF ATHEROSCLEROTIC HEART DISEASE AND BRACHIOCEPHALIC ARTERIES LESIONS IN RHEUMATOID ARTHRITIS123
AB0427 RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: A DIFFICULT-TO-TREAT CLINICAL CASE123
AB0345 THERAPEUTIC DRUG LEVELS TO ACHIEVE GOOD EULAR RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB: RESULTS FROM THE BIOLOGICS IN RHEUMATOID ARTHRITIS GENETICS AND GENOMICS STUDY121
AB0632 Intracardiac thrombosis and vascular involvement in Behçet's disease : two sides of the same coin ?120
AB0563 ALEXITHYMIA IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS113
AB0761 Are we treating-to-target in spondyloarthritis (SpA)? A cross sectional analysis from the Asia Pacific League of Associations for Rheumatology (APLAR) SpA Registry111
AB0267 FEATURES OF CARDIAC PATHOLOGY IN PATIENTS WITH SECONDARY OSTEOARTHRITIS ON THE BACKGROUND OF RHEUMATOID ARTHRITIS111
AB0398 AURICULAR TRANSCUTANEOUS HI-FREQUENCY E-MMUNOTHERAPY SEQUENCES (ATHENS) FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: 1-YEAR CHANGES IN SYNOVITIS, OSTEITIS, AND BONE EROSION110
AB1019 THE EFFECTS OF THREE DIFFERENT VITAMIN D3 SUPPLEMENTATION REGIMENS IN DEFICIENT SUBJECTS ON INFLAMMATORY CYTOKINES – A RANDOMISED OPEN-LABEL PARALLEL GROUPS STUDY109
AB1437 RHEUMATOLOGICAL IMMUNE-MEDIATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS BASED ON THE FDA ADVERSE EVENTS REPORTING SYSTEM106
AB0285 MTX REDUCED THE CARDIOVASCULAR RISK IN RHEUMATIC DISEASES105
AB0640 PREVALENCE AND DETERMINANT FACTORS OF ENDOTHELIAL DYSFUNCTION IN ANCA ASSOCIATED VASCULITIS105
AB1448 DEEP VENOUS THROMBOSIS IN YOUNG ADULTS: INCIDENCE AND RISK FACTORS104
AB1331 DIAGNOSTIC CAPABILITY OF ANESTHETIC INTRA-ARTICULAR INJECTIONS FOR FEMOROACETABULAR IMPINGEMENT100
AB0878 Higher vitamin D serum level is associated with a better clinical response to bDMARDs in patients with axial spondyloarthritis.99
AB1127 ANTIOSTEOPOROTIC TREATMENT AND COVID-19 RISK: IS THERE AN ASSOCIATION?96
AB0795 Are patients with ankylosing spondylitis afraid of falling compared to healthy controls?: the role of balance and posture96
AB1207 RISK FACTORS FOR HIGHER RELAPSE RATE AND/OR PROLONGED GLUCOCORTICOID THERAPY IN POLYMYALGIA RHEUMATICA: MULTICENTRE STUDY IN 185 PATIENTS95
AB0642 Diagnosis of Cerebral vasculitis: retrospective study of 68 cases93
AB0767 Comparison of the clinical-laboratory remission and the ASAS partial remission in patients with early axial spondyloarthritis92
AB0928 CHARACTERISTICS OF AXIAL PSORIATIC ARTHRITIS PATIENTS WITH SYMMETRICAL AND ASYMMETRICAL SACROILIITIS89
AB1123 EFFICACY AND SAFETY OF SARS-CoV-2 THIRD VACCINE IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO DID NOT RESPOND AFTER PRIMARY TWO-DOSE REGIMEN87
AB1351 FULL LONGITUDINAL NAILFOLD VIDEOCAPILLAROSCOPY ANALYSIS OF MICROVASCULAR CHANGES DURING NORMAL PREGNANCY86
AB0826 Keep an Eye on the Back: Spondyloarthritis in Patients with Acute Anterior Uveitis85
AB1330 AUTOMATIC SUBPIXEL MEASUREMENT OF RADIOGRAPHIC FINGER JOINT SPACE NARROWING IN RHEUMATOID ARTHRITIS PATIENTS UNDER TOCILIZUMAB TREATMENT85
AB1025 TRABECULAR BONE SCORE IN PATIENTS WITH AXIAL-SPONDYLOARTHRITIS85
AB0882 Guselkumab: description of cardiovascular risk and efficacy in psoriasis and psoriatic arthritis in real clinical practice85
AB1419 PERFORMANCE OF AN EARLY TRIAGE SYSTEM FOR IDENTIFICATION OF PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES85
AB0311 RHEUMATOID ARTHRITIS AND OSTEOPOROSIS: FREQUENCY AND ASSOCIATED FACTORS85
POS0360-PARE EDUCATIONAL NEEDS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTH PROFESSIONALS IN RHEUMATOLOGY: A SWISS CROSS-SECTIONAL QUALITATIVE ANALYSIS80
POS0851 FREQUENCY OF METABOLIC SYNDROME AND ITS RELATIONSHIP WITH DISEASE CHARACTERISTICS IN PATIENTS WITH SYSTEMIC SCLEROSIS79
POS1337 ADULT-ONSET STILL'S DISEASE WITH ELDERLY ONSET, RESULTS FROM A MULTICENTRE STUDY AND ASSESSMENT OF AGE INFLUENCE ON CLINICAL FEATURES AND DISEASE OUTCOMES.78
POS1566-PARE BEYOND MEDICATION – SELF MANAGEMENT AS A COMPLEMENTARY APPROACH FOR TREATING RMDS78
POS1470-HPR KNOWING WHAT TO DO WITH THE DATA - A QUALITATIVE STUDY ON CHALLENGES OF USING SMARTPHONE-BASED ePROs IN RHEUMATOID ARTHRITIS77
POS1189 RHEUMATIC FEVER AND CUTANEOUS STREPTOCOCCAL INFECTION: A CASE-CONTROL STUDY IN THE LOYALTY ISLANDS, NEW CALEDONIA74
POS1348 PATIENTS WITH VEXAS DIAGNOSED IN A DANISH TERTIARY RHEUMATOLOGY SETTING HAVE HIGHLY ELEVATED INFLAMMATORY MARKERS, MACROCYTIC ANEMIA, AND NEGATIVE AUTOIMMUNE BIOMARKERS.74
POS0897 A SYSTEMATIC REVIEW AND META-ANALYSIS OF DIAGNOSTIC ACCURACY OF WHOLE-BODY 18F-FDG PET AND 18F-FDG PET/CT IN DETECTING OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHY74
POS1270 COVID19 VACCINATION IN PATIENTS WITH AXIAL AND PERIPHERAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: ADVERSE EVENTS AND IMPACT ON DISEASE ACTIVITY74
News from EULAR74
0.096346855163574